Health
Pfizer aims for $15bn in 2021 COVID-19 vaccine sales – PMLiVE
Current estimate is based on already agreed contracts
Pfizer has forecast major sales expectations for its BioNTech-partnered COVID-19 vaccine, BNT162b2, in its fourth quarter results – aiming for approximately $15bn in revenues for 2021.
The company said that the 2021 guidance for the vaccine mainly includes doses that are expected to be delivered in the year under existing contracts, adding that it may be adjusted dependent on future additional contracts.
In the fourth quarter of 2020 alone BNT162b2 contributed $154m to Pfizer’s overall sales.
For…
-
General23 hours agoEnglish springer spaniels Kelly and Milo helping fight dieback in Western Australia
-
Noosa News19 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
Noosa News12 hours agoNRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership
-
General12 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final